0.96
price up icon4.03%   0.0372
after-market Handel nachbörslich: .93 -0.03 -3.12%
loading

Io Biotech Inc Aktie (IOBT) Neueste Nachrichten

pulisher
Apr 26, 2025

IO Biotech's Co-Founder Mads Hald Andersen Highlights Advances in Cancer Vaccine Research at 2025 AACR Annual Meeting - Nasdaq

Apr 26, 2025
pulisher
Apr 26, 2025

IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025 - The Globe and Mail

Apr 26, 2025
pulisher
Apr 25, 2025

IO Biotech unveils promising vaccine preclinical data By Investing.com - Investing.com India

Apr 25, 2025
pulisher
Apr 25, 2025

IO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170 - The Manila Times

Apr 25, 2025
pulisher
Apr 25, 2025

Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting - The Manila Times

Apr 25, 2025
pulisher
Apr 25, 2025

New Cancer Vaccine Data Shows Powerful Immune Response in Multiple Tumors | IOBT Stock News - Stock Titan

Apr 25, 2025
pulisher
Apr 25, 2025

Short Sellers Gave Up on These 3 Names Recently - The Globe and Mail

Apr 25, 2025
pulisher
Apr 25, 2025

4 Cheap Stocks With Solid Fundamentals to Offset Market Uncertainty - The Globe and Mail

Apr 25, 2025
pulisher
Apr 25, 2025

Cotton Extending Strength to Friday Morning - The Globe and Mail

Apr 25, 2025
pulisher
Apr 24, 2025

Healthcare Services (HCSG) Receives a Hold from William Blair - The Globe and Mail

Apr 24, 2025
pulisher
Apr 24, 2025

3 Reasons AMTM is Risky and 1 Stock to Buy Instead - The Globe and Mail

Apr 24, 2025
pulisher
Apr 23, 2025

Nano One 2025 Annual General Meeting of Shareholders - The Globe and Mail

Apr 23, 2025
pulisher
Apr 23, 2025

Boeing doesn't expect the US trade war with China to slow its recovery - The Globe and Mail

Apr 23, 2025
pulisher
Apr 22, 2025

[WATCH] Trading Gaps: Spot Big Moves Before They Happen - The Globe and Mail

Apr 22, 2025
pulisher
Apr 22, 2025

Limbach (LMB): Buy, Sell, or Hold Post Q4 Earnings? - The Globe and Mail

Apr 22, 2025
pulisher
Apr 18, 2025

Pre-market Movers: OPTN, WINT, AKBA, GCTK... - RTTNews

Apr 18, 2025
pulisher
Apr 17, 2025

Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC - The Globe and Mail

Apr 17, 2025
pulisher
Apr 16, 2025

Viking Therapeutics Stock Pops But Struggles to Hold Gains - The Globe and Mail

Apr 16, 2025
pulisher
Apr 15, 2025

CrowdStrike Stock is a Buy as Cyberthreat Environment Expands - The Globe and Mail

Apr 15, 2025
pulisher
Apr 14, 2025

5 Top Psychedelic Stocks (2025) for Mental Health Investing - Securities.io

Apr 14, 2025
pulisher
Apr 12, 2025

We're A Little Worried About IO Biotech's (NASDAQ:IOBT) Cash Burn Rate - Yahoo Finance

Apr 12, 2025
pulisher
Apr 10, 2025

Metastatic Melanoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail

Apr 10, 2025
pulisher
Apr 10, 2025

Google (GOOGL) Offers U.S. Government Major Discounts as It Challenges Microsoft - The Globe and Mail

Apr 10, 2025
pulisher
Apr 10, 2025

Seeking High Dividend Yield? Earn 9.6% from This Energy Stock Now. - The Globe and Mail

Apr 10, 2025
pulisher
Apr 10, 2025

Tetra Tech Awarded £36 Million Multiple-Award Contract for Water Infrastructure Services - The Globe and Mail

Apr 10, 2025
pulisher
Apr 09, 2025

NESR to Participate in Water Tower Research Fireside Chat on April 10 at 11am ET - The Globe and Mail

Apr 09, 2025
pulisher
Apr 08, 2025

Financial Survey: Vistagen Therapeutics (NASDAQ:VTGN) versus IO Biotech (NASDAQ:IOBT) - Defense World

Apr 08, 2025
pulisher
Apr 08, 2025

WSP Global Inc. (TSE:WSP) Receives C$284.85 Consensus Target Price from Brokerages - Defense World

Apr 08, 2025
pulisher
Apr 08, 2025

Evergy, Inc. (NASDAQ:EVRG) Receives $69.08 Average Price Target from Brokerages - Defense World

Apr 08, 2025
pulisher
Apr 08, 2025

Brokerages Set Aspen Aerogels, Inc. (NYSE:ASPN) PT at $19.11 - Defense World

Apr 08, 2025
pulisher
Apr 07, 2025

Ag Futures Markets Are Suffering a Severe Case of Tariff Indigestion. When Will They Rebound? - The Globe and Mail

Apr 07, 2025
pulisher
Apr 06, 2025

Prediction: This Artificial Intelligence (AI) Semiconductor Stock Could Start Soaring After April 16 - The Globe and Mail

Apr 06, 2025
pulisher
Apr 05, 2025

Q1 Earnings Forecast for IO Biotech Issued By HC Wainwright - Defense World

Apr 05, 2025
pulisher
Apr 05, 2025

Globus Medical acquires Nevro Corp. - Medical Buyer

Apr 05, 2025
pulisher
Apr 04, 2025

Is Nvidia Stock a Buy or Sell Below $100 as a Global Trade War Escalates? - The Globe and Mail

Apr 04, 2025
pulisher
Apr 02, 2025

IO Biotech (NASDAQ:IOBT) Given “Buy” Rating at HC Wainwright - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

Fresh Quarter, Fresh Momentum? Markets Eye April 2nd Tariff Announcement - The Globe and Mail

Apr 01, 2025
pulisher
Mar 31, 2025

IO Biotech Inc. (IOBT) reports earnings - qz.com

Mar 31, 2025
pulisher
Mar 28, 2025

New PM2 Gene Discovery by Aurora Cannabis Enhances Disease Resistance - Securities.io

Mar 28, 2025
pulisher
Mar 28, 2025

Alcon acquires majority stake in Aurion Biotech - Healio

Mar 28, 2025
pulisher
Mar 27, 2025

IO Biotech secures over 400 million dkk in new capital - Dansk Industri

Mar 27, 2025
pulisher
Mar 26, 2025

IO Biotech Announces Acceptance of Abstracts to be Presented at the 2025 American Association for Cancer Research (AACR) Annual Meeting - The Manila Times

Mar 26, 2025
pulisher
Mar 25, 2025

IO Biotech Announces Acceptance Of Abstracts To Be Presented At The 2025 American Association For Cancer Research (AACR) Annual Meeting - MarketScreener

Mar 25, 2025
pulisher
Mar 25, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Mar 25, 2025
pulisher
Mar 24, 2025

Palantir Insiders including PLTR CEO Dump Shares as Valuation Skyrockets 340% - The Globe and Mail

Mar 24, 2025
pulisher
Mar 21, 2025

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - The Globe and Mail

Mar 21, 2025
pulisher
Mar 20, 2025

Why Five Below Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Benzinga

Mar 20, 2025
pulisher
Mar 19, 2025

TCEHY Earnings: Tencent Profits Leap on Gaming and Ads as Investors Wait on AI Returns - The Globe and Mail

Mar 19, 2025
pulisher
Mar 18, 2025

IO Biotech Named Among Fast Company's World's Most Innovative Companies of 2025 - The Manila Times

Mar 18, 2025
pulisher
Mar 18, 2025

IO Biotech Named Among Fast Company’s World’s Most Innovative Companies of 2025 - TradingView

Mar 18, 2025
pulisher
Mar 18, 2025

Fast Company Names IO Biotech Top 10 Innovator for Cancer Vaccine Breakthrough - StockTitan

Mar 18, 2025
pulisher
Mar 18, 2025

These 10 biotech companies are changing how we discover new drugs and treat complex diseases - Fast Company

Mar 18, 2025
pulisher
Mar 17, 2025

Partex and Fortress Biotech Announce Strategic - GlobeNewswire

Mar 17, 2025
pulisher
Mar 15, 2025

IO Biotech (NASDAQ:IOBT) Upgraded at Piper Sandler - Defense World

Mar 15, 2025
pulisher
Mar 13, 2025

Cancer Vaccines Market Analysis: Growth Drivers - openPR.com

Mar 13, 2025
pulisher
Mar 13, 2025

Why BlackRock’s Panama Deal Highlights the Value of Real Asset ETFs - The Globe and Mail

Mar 13, 2025
pulisher
Mar 12, 2025

Bavarian Nordic A/S – Notice Convening Annual General Meeting - Finansavisen

Mar 12, 2025
pulisher
Mar 07, 2025

HC Wainwright Reiterates “Buy” Rating for IO Biotech (NASDAQ:IOBT) - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

Promising Clinical Developments and Delayed Data Boost IO Biotech’s Buy Rating - TipRanks

Mar 07, 2025
pulisher
Mar 06, 2025

Best Biotech Stocks to Buy in 2025 - The Motley Fool

Mar 06, 2025
pulisher
Mar 05, 2025

Ratio Chart Of U.S. Dollar Index Against 10Y U.S. Notes Is Pointing Much Lower - The Globe and Mail

Mar 05, 2025
pulisher
Mar 05, 2025

Melanoma Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail

Mar 05, 2025
pulisher
Mar 05, 2025

Melanoma Clinical Trials and Studies: EMA, PDMA, FDA Approvals, - openPR

Mar 05, 2025
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Kapitalisierung:     |  Volumen (24h):